Moderna’s stock rises on 2023 product sales of $6.7B

Post Content

Johnson & Johnson to acquire Ambrx in $2 billion deal

Post Content

Newell Brands to cut office staff by 7% by the end of the year

Post Content

Novartis, Cytokinetics near merger: report

Post Content